IndraLab

Statements

USP8 activates Carcinoma, Non-Small-Cell Lung. 1 / 2

| 1

reach

"Indeed, inhibition of USP8 either by its knockdown or synthetic small molecule led to attenuation of variety of receptor tyrosine kinase (RTK) activities, resulting in the inhibition of cell proliferation in gefitinib-resistant and -sensitive non-small cell lung cancer (NSCLC) cells [47] ."

26077642

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP8 activates Carcinoma, Non-Small-Cell Lung. 1 / 2

INDRA sources:

Databases

Reading